Smith & Nephew

Founders Thomas James Smith

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$11M
Portfolio companies 3
Rounds per year 0.03
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 1
Key employees Soon

Areas of investment

  • Medical Device
  • Medical
  • Biotechnology
  • Health Care
  • Health Diagnostics
Summary

Smith & Nephew appeared to be the Corporate Investor, which was created in 1856. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined Corporate Investor is situated in the London.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Smith & Nephew, startups are often financed by BioStar Ventures, Safeguard Scientifics, Octopus Ventures. The meaningful sponsors for the fund in investment in the same round are Triventures, Safeguard Scientifics, HealthpointCapital. In the next rounds fund is usually obtained by Triventures, Safeguard Scientifics, Municipal Employee Retirement System.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Trice Medical, Michelson Diagnostics, OrthoSpace. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Diagnostics.

The high activity for fund was in 2015. This Smith & Nephew works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Smith & Nephew:
Typical Co-investors
Smith & Nephew is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Smith & Nephew:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Atelier Ventures Pennsylvania, Pittsburgh, United States
Cito Ventures Florida, Miami, United States
Debenhams England, London, United Kingdom
ECMC Oakdale, Pennsylvania, United States
George Weston Limited Canada, Ontario, Toronto
Guangzhou Zhangsu Investment Consulting Co., Ltd China, Guangdong, Panyu
HLVP Delaware, Ohio, United States
Hubei Forbon Technology -
InnoCells Barcelona, Catalonia, Spain
Jiaxing Jince Yunji Investment Partnership -
NCL Innovation -
Ningbo Meishan Baoshui Gangqu Saiyi Boying Touzi Guanli Zhongxin China, Ningbo, Zhejiang
Reliance Technology Ventures India, Maharashtra, Mumbai
Rowan Dartington Bristol, England, United Kingdom
SB Payment Service Japan, Tokyo
Spring California, San Francisco, United States
TMG Capital Brazil, São Paulo, Sao Paulo
Xiaozhan Jiaoyu China, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Trice Medical

Health Care
Health Diagnostics
Medical
Medical Device
$18M14 Jan 2019 Pennsylvania, United States

Trice Medical

Health Care
Health Diagnostics
Medical
Medical Device
$19M06 Jun 2017 Pennsylvania, United States

OrthoSpace

Biotechnology
Medical
Medical Device
$7M01 Dec 2016 North District

OrthoSpace

Biotechnology
Medical
Medical Device
$8M19 May 2015 North District

Michelson Diagnostics

Biotechnology
Health Care
Health Diagnostics
Manufacturing
Medical Device
$2M16 Feb 2015 England

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Smith & Nephew?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: